Contact this trialFirst, we need to learn more about you.
Topical Gel
HT-001 for Skin Side Effects from Cancer Therapy
Recruiting0 awardsPhase 2
Boston, Massachusetts
This trial will explore if HT-001 Topical Gel can safely reduce skin toxicities associated with EGFR inhibitors and improve patient quality of life.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service